Andrew Obenshain - Jan 10, 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Jan 10, 2022
Transactions value $
-$73,623
Form type
4
Date filed
1/12/2022, 08:15 PM
Previous filing
Dec 9, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Sale -$7.88K -852 -0.33% $9.24 254K Jan 10, 2022 Direct F1, F2
transaction BLUE Common Stock Sale -$20.6K -2.19K -0.86% $9.40 251K Jan 10, 2022 Direct F1, F3
transaction BLUE Common Stock Sale -$45.2K -4.68K -1.86% $9.64 247K Jan 11, 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 The range in prices for the transaction reported on this line was $8.96 to $9.36. The average weighted price was $9.2445. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The range in prices for the transaction reported on this line was $9.385 to $9.42. The average weighted price was $9.4022. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The range in prices for the transaction reported on this line was $9.48 to $9.83. The average weighted price was $9.6426. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.